Free Republic

Doctors are calling for a clinical trial of an experimental drug treatment that it is claimed can reverse the symptoms of Alzheimer's disease "in minutes". U.S. researchers say the treatment allowed an 82-year- old sufferer to recognise his wife for the first time in years. In the UK, specialists believe the claims should be properly tested as only a few patients have been treated so far. The treatment involves injecting a drug called Enbrel - which is normally used to treat arthritis - into the spine at the neck. Patients are then tilted to encourage blood flow into the brain...

A new study of a promising Alzheimer's treatment has doctors buzzing that the drug may reverse the deadly neurodegenerative disease. But the new treatment isn't a new drug at all, rather a skin cancer pill that's been FDA-approved for more than a decade. The drug, bexarotene, reversed signs of Alzheimer's in mice brains and also improved their memory in as little as 72 hours, according to the study. "This is an unprecedented finding," study author Paige Cramer, a PhD candidate at Case Western Reserve School of Medicine, said in a university written statement. "Previously, the best existing treatment for Alzheimer's...

We've been waiting and hoping that the Rhinestone Cowboy might come to Orange County one last time before finally hanging up his microphone, but it doesn't seem likely now -- not when a huge farewell has been slated for the Hollywood Bowl. As has been widely reported -- and repeated Sunday night just before the Lifetime Achievement Award honoree took the stage for a rousing, admirable tribute at the Grammys -- Glen Campbell, 76, is facing the onset of Alzheimer's by embarking on a farewell trek (The Goodbye Tour) behind one final album, his 61st (!), last August's acclaimed Ghost...

A skin cancer drug has reversed Alzheimer's in mice - raising hope that it could be similarly successful against the incurable disease in humans. Now families of Alzheimer's sufferers are now bombarding physicians with requests for the drug, called bexarotene and marketed as Targretin. In research published in the journal Science, mice were engineered to exhibit Alzheimer's symptoms - such as forgetfulness and rapid cell death. After they took the drug, they became instantly smarter, performing better Researchers at Case Western Reserve University in Cleveland, Ohio added that plaque in the mice brains that was causing Alzheimer's had started to...

A widely available cancer drug has shown remarkable success in reversing Alzheimer's disease in mice, raising hope of a breakthrough against incurable dementia in humans, US researchers said Thursday. Mice treated with the drug, known as bexarotene, became rapidly smarter and the plaque in their brains that was causing their Alzheimer's started to disappear within hours, said the research in the journal Science. "We were shocked and amazed," lead author Gary Landreth of the Department of Neurosciences at Case Western Reserve University School of Medicine in Ohio told AFP. "Things like this had never, ever been seen before," he said....

Alzheimer’s disease seems to spread like an infection from brain cell to brain cell, two new studies in mice have found. But instead of viruses or bacteria, what is being spread is a distorted protein known as tau. The surprising finding answers a longstanding question and has immediate implications for developing treatments, researchers said. And they suspect that other degenerative brain diseases like Parkinson’s may spread in a similar way. Alzheimer’s researchers have long known that dying, tau-filled cells first emerge in a small area of the brain where memories are made and stored. The disease then slowly moves outward...

Clarksburg, MD—Two different research groups have independently made the same important discoveries on how Alzheimer’s disease spreads in the brain, according to a February 2 New York Times story. The groups’ findings have the potential to give us a much more sophisticated understanding of what goes wrong in Alzheimer’s disease and, more importantly, what can be done to prevent or repair damage in the brain. The Times reported on the research teams of Bradley T. Hyman, MD, Ph.D., at Massachusetts General Hospital in Boston, and Karen E. Duff, Ph.D., of Columbia University Medical Center in New York. Each research group...

Research into how iron, copper, zinc and other metals work in the brain may help unlock some of the secrets of degenerative diseases like Alzheimer's and Parkinson's. Iron and copper appear to accumulate beyond normal levels in the brains of people with these diseases, and a new, Australian study published Sunday shows reducing excess iron in the brain can alleviate Alzheimer's-like symptoms—at least in mice. A genetic mutation related to regulating iron is linked to ALS, or Lou Gehrig's disease. Zinc, on the other hand, appears to impair memory if its levels get too low or if it gets into...

TED Event - a talk by Dr. Terry Wahls about how she essentially cured her own MS through diet.

CORVALLIS, Ore. – New research has found that elderly people with higher levels of several vitamins and omega 3 fatty acids in their blood had better performance on mental acuity tests and less of the brain shrinkage typical of Alzheimer's disease – while "junk food" diets produced just the opposite result. The study was among the first of its type to specifically measure a wide range of blood nutrient levels instead of basing findings on less precise data such as food questionnaires, and found positive effects of high levels of vitamins B, C, D, E and the healthy oils most...

Scientists have isolated a gene in mice that works to give them "super memories" and reverses the course of several degenerative mental illnesses like Alzheimer's. And because of the similarity of mice and human brains, a powerful brain pill for humans may now not be far off. The brains of both mice and humans release a gene known as PKR, which is triggered by the onset of Alzheimer's. But the newly discovered gene can apparently block PKR's release--a development that not only can reverse the course of degenerative brain diseases such as Alzheimer's, but induces a state of "super memory"...

Statins, traditionally known as cholesterol-lowering drugs, may reduce mortality among patients hospitalized with influenza, according to a new study released online by the Journal of Infectious Diseases. It is the first published observational study to evaluate the relationship between statin use and mortality in hospitalized patients with laboratory-confirmed influenza virus infection, according to Vanderbilt's William Schaffner, M.D., professor and chair of Preventive Medicine. "We may be able to combine statins with antiviral drugs to provide better treatment for patients seriously ill with influenza," said Schaffner, who co-authored the study led by Meredith Vandermeer, MPH, of the Oregon Public Health Division.

Salk scientists develop new drug that improves memory and prevents brain damage in miceA new drug candidate may be the first capable of halting the devastating mental decline of Alzheimer's disease, based on the findings of a study published today in PLoS one. When given to mice with Alzheimer's, the drug, known as J147, improved memory and prevented brain damage caused by the disease. The new compound, developed by scientists at the Salk Institute for Biological Studies, could be tested for treatment of the disease in humans in the near future. "J147 enhances memory in both normal and Alzheimer's mice...

A surprisingly simple method to target harmful proteinsTroy, N.Y. – Researchers at Rensselaer Polytechnic Institute have developed a new method to design antibodies aimed at combating disease. The surprisingly simple process was used to make antibodies that neutralize the harmful protein particles that lead to Alzheimer's disease. The process is reported in the Dec. 5 Early Edition of the journal Proceedings of the National Academy of Sciences (PNAS). The process, outlined in the paper, titled "Structure-based design of conformation- and sequence-specific antibodies against amyloid β," could be used as a tool to understand complex disease pathology and develop new antibody-based...

A red dye derived from lichens that has been used for centuries to color fabrics and food appears to reduce the abundance of small toxic protein aggregates in Alzheimer’s disease. The dye, a compound called orcein, and a related substance, called O4, bind preferentially to small amyloid aggregates that are considered to be toxic and cause neuronal dysfunction and memory impairment in Alzheimer’s disease. O4 binding to small aggregates promotes their conversion into large, mature plaques which researchers assume to be largely non-toxic for neuronal cells. Further research with animal models is needed to determine whether this new approach by...

CHICAGO – People who eat baked or broiled fish on a weekly basis may be improving their brain health and reducing their risk of developing mild cognitive impairment (MCI) and Alzheimer's disease, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). "This is the first study to establish a direct relationship between fish consumption, brain structure and Alzheimer's risk," said Cyrus Raji, M.D., Ph.D., from the University of Pittsburgh Medical Center and the University of Pittsburgh School of Medicine. "The results showed that people who consumed baked or broiled fish at...

For decades the amyloid hypothesis has dominated the research field in Alzheimer’s disease. The theory describes how an increase in secreted beta-amyloid peptides leads to the formation of plaques, toxic clusters of damaged proteins between cells, which eventually result in neurodegeneration. Scientists at Lund University, Sweden, have now presented a study that turns this premise on its head. The research group’s data offers an opposite hypothesis, suggesting that it is in fact the neurons’ inability to secrete beta-amyloid that is at the heart of pathogenesis in Alzheimer’s disease. The study, published in the October issue of the Journal of Neuroscience,...

DURHAM, N.C. - Immune system cells of the brain, which scavenge pathogens and damaged neurons, are also key players in memory and learning, according to new research by Duke neuroscientists. Earlier studies by Staci Bilbo, an assistant professor in psychology & neuroscience, had shown that laboratory rats experiencing an infection at an early age have an aggressive immune response to subsequent infections, which also harms their learning and memory. In a study published in the Oct. 26 Journal of Neuroscience, Bilbo's team identifies the source of the learning difficulties and traces it back to the immune system itself. The researchers...

HOUSTON -- The brain damage that characterizes Alzheimer's disease may originate in a form similar to that of infectious prion diseases such as bovine spongiform encephalopathy (mad cow) and Creutzfeldt-Jakob, according to newly published research by The University of Texas Health Science Center at Houston (UTHealth). "Our findings open the possibility that some of the sporadic Alzheimer's cases may arise from an infectious process, which occurs with other neurological diseases such as mad cow and its human form, Creutzfeldt-Jakob disease," said Claudio Soto, Ph.D., professor of neurology at The University of Texas Medical School at Houston, part of UTHealth. "The...

AUGUSTA, Ga. – An accomplice to the protein that causes plaque buildup in Alzheimer's disease is the focus of a potential new treatment, according to research by a Georgia Health Sciences University graduate student. In Alzheimer's, the amyloid protein can accumulate in the brain instead of being eliminated by the body's natural defenses, nestling between the neurons and forming impassable plaques. Amyloid and the way it gets there could be targets for a new vaccine. "RAGE, or receptor for advanced glycation endproducts, proteins bind to amyloid and transport it into the brain," said Scott Webster, a fifth-year graduate student who...

Up-and-down cycle flattens as age disrupts pattern A marker for Alzheimer's disease rises and falls in the spinal fluid in a daily pattern that echoes the sleep cycle, researchers at Washington University School of Medicine in St. Louis have found. The pattern is strongest in healthy young people and reinforces a link between increased Alzheimer's risk and inadequate sleep that had been discovered in animal models. The brain's relative inactivity during sleep may provide an opportunity to finish clearing away the Alzheimer's marker, a byproduct of brain activity called amyloid beta. The body clears amyloid beta from the brain through...

Long time televangelist and former presidential candidate Pat Robertson stunned the conservative Christian world on Tuesday when he said that it would be okay for man to divorce his wife who has Alzheimer’s. During the Tuesday broadcast of the 700 Club, Robertson was responding to a question he received from a viewer. In his response, Robertson said that people with Alzheimer’s are ‘walking dead’ who in his opinion would make it acceptable for a spouse to seek a divorce. One has to wonder if Robertson would feel the same way if he were the one with Alzheimer’s who was being...

Religious broadcaster Pat Robertson told his "700 Club" viewers that divorcing a spouse with Alzheimer's is justifiable because the disease is "a kind of death." During the portion of the show where the one-time Republican presidential candidate takes questions from viewers, Robertson was asked what advice a man should give to a friend who began seeing another woman after his wife started suffering from the incurable neurological disorder. "I know it sounds cruel, but if he's going to do something, he should divorce her and start all over again, but make sure she has custodial care and somebody looking after...

Religious broadcaster Pat Robertson told his "700 Club" viewers that divorcing a spouse with Alzheimer's is justifiable because the disease is "a kind of death." During the portion of the show where the one-time Republican presidential candidate takes questions from viewers, Robertson was asked what advice a man should give to a friend who began seeing another woman after his wife started suffering from the incurable neurological disorder.

Researchers may have solved 100-year-old puzzle ITHACA, N.Y. — Cornell University researchers may have solved a 100-year puzzle: How to safely open and close the blood-brain barrier so that therapies to treat Alzheimer's disease, multiple sclerosis and cancers of the central nervous system might effectively be delivered. (Journal of Neuroscience, Sept. 14, 2011.) The researchers found that adenosine, a molecule produced by the body, can modulate the entry of large molecules into the brain. For the first time, the researchers discovered that when adenosine receptors are activated on cells that comprise the blood-brain barrier, a gateway into the blood-brain barrier...

Glen Campbell, who has Alzheimer’s, has released a superb 'final' album at the age of 75. “Ghost on the Canvas” is Glen Campbell’s album of a lifetime...literally. The stunning set, out Aug. 30, reflects on the multiple Grammy winner’s career and times often through the prism of his life-altering diagnosis of Alzheimer’s Disease. The 75-year old announced he had the disease earlier this year and that “Ghost on the Canvas” would be his final album. He starts a goodbye tour later this fall. Without ever skirting the dire future he now faces, Campbell and producer/co-writer Julian Raymond, have made a...

PHILADELPHIA - It seems the Eagles aren't the only team in town ready for some NFL action. The lawyers of Anapol, Schwartz, Weiss, Cohan, Feldman and Smalley have taken on the National Football League in federal court. Seven former professional football players -- among them former Chicago Bears and Philadelphia Eagles quarterback Jim McMahon and Philadelphia Eagles lineman Gerry Feehery -- retained the Philadelphia law firm, alleging the NFL failed ...

Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria. Judith Miklossy Correspondence: Judith Miklossy judithmiklossy@bluewin.ch Journal of Neuroinflammation 2011, 8:90 doi:10.1186/1742-2094-8-90 Published: 4 August 2011 Abstract (provisional) It is established that chronic spirochetal infection can cause slowly progressive dementia, brain atrophy and amyloid deposition in late neurosyphilis. Recently it has been suggested that various types of spirochetes, in an analogous way to Treponema pallidum, could cause dementia and may be involved in the pathogenesis of Alzheimer's disease (AD). Here, we review all data available in the literature on the detection of spirochetes in AD and...

A Drink a Day May Keep Alzheimer's Away Fran Lowry   August 26, 2011 — Light to moderate drinking seems to reduce the risk for dementia and cognitive decline, according to a new study published in the August issue of Neuropsychiatric Disease and Treatment. A meta-analysis of 143 studies on the effects of alcohol on the brain showed that moderate drinking, defined as no more than 2 drinks a day for a man and no more than 1 drink a day for a woman, reduced the risk for Alzheimer's disease and other forms of dementia by 23%. "It doesn't seem...

Scientists at Yale University have developed the first practical method to create a compound called huperzine A in the lab. The compound, which occurs naturally in a species of moss found in China, is an enzyme inhibitor that has been used to treat Alzheimer's disease in China since the late 1990s and is sold in the U.S. as a dietary supplement to help maintain memory. Scientists believe it could also potentially combat the effects of chemical warfare agents. Until now, researchers have only been able to derive small amounts of the compound directly from the Huperzia serrata plant, or had...

For such a strong figure, Pat Summitt was feeling almost helpless. Months of erratic behavior had left the Tennessee women’s basketball coach bewildered, scared and asking herself “What’s wrong with me?” Summitt went to the Mayo Clinic in Rochester, Minn., in May. She underwent a series of tests and received a stunning answer. The diagnosis was early onset dementia, Alzheimer’s type.

Researchers discover common cause of all forms of ALSCHICAGO --- The underlying disease process of amyotrophic lateral sclerosis (ALS and Lou Gehrig's disease), a fatal neurodegenerative disease that paralyzes its victims, has long eluded scientists and prevented development of effective therapies. Scientists weren't even sure all its forms actually converged into a common disease process. But a new Northwestern Medicine study for the first time has identified a common cause of all forms of ALS. The basis of the disorder is a broken down protein recycling system in the neurons of the spinal cord and the brain. Optimal functioning of...

Researchers at Lund University have discovered a new function for vitamin C. Treatment with vitamin C can dissolve the toxic protein aggregates that build up in the brain in Alzheimer's disease. The research findings are now being presented in the Journal of Biological Chemistry. The brains of people with Alzheimer's disease contain lumps of so-called amyloid plaques which consist of misfolded protein aggregates. They cause nerve cell death in the brain and the first nerves to be attacked are the ones in the brain's memory centre. "When we treated brain tissue from mice suffering from Alzheimer's disease with vitamin C,...

PROVIDENCE, R.I. – Researchers at Rhode Island Hospital's Alzheimer's Disease and Memory Disorders Center have found positive associations between fish oil supplements and cognitive functioning as well as differences in brain structure between users and non-users of fish oil supplements. The findings suggest possible benefits of fish oil supplements on brain health and aging. The results were reported at the recent International Conference on Alzheimer's Disease, in Paris, France. The study was led by Lori Daiello, PharmD, a research scientist at the Rhode Island Hospital Alzheimer's Disease and Memory Disorders Center. Data for the analyses was obtained from the Alzheimer's...

The blood of patients with the brain disease contains antibodies not found in healthy people. A new blood test diagnoses Alzheimer's disease by sensing molecules produced by the immune systems of people with the neurodegenerative condition. So far, the test has been applied to just a small number of blood samples, but if proven on a larger scale, the assay could help diagnose Alzheimer's disease in combination with other tests, says Thomas Kodadek, a professor of chemistry at the Scripps Research Institute in Jupiter, Florida. It could also be used to identify patients for trials of experimental Alzheimer's drugs, he...

Psychologist Margaret Gatz explains what 25 years of research have taught her about reducing the risk of dementia. Margaret Gatz, a psychologist at the University of Southern California, Los Angeles, is investigating the causes of Alzheimer's disease. To that end, she has studied the health of more than 14,000 Swedish twins for more than 25 years. On 5 August, she will tell the annual convention of the American Psychological Association in Washington DC what the study has taught her about how to reduce risk for the disease. Nature got a preview. What first motivated you to study Alzheimer's disease? Before...

People with rare, inherited forms of the neurological disease have early markers—which researchers can use to test preventive treatments. For the first time, scientists have been able to detect signs of Alzheimer's disease 10 to 20 years before the onset of dementia. The study, presented Wednesday at the Alzheimer's Association International Conference in Paris, focused on people with rare, inherited forms of the disease who develop it relatively young, with symptoms beginning in the patients' 30s, 40s, and 50s. Researchers say the results will help them test drugs that could prevent or slow the progression of the disease, not only...

A yet unidentified component of coffee interacts with the beverageÂ’s caffeine, which could be a surprising reason why daily coffee intake protects against AlzheimerÂ’s disease. A new AlzheimerÂ’s mouse study by researchers at the University of South Florida found that this interaction boosts blood levels of a critical growth factor that seems to fight off the AlzheimerÂ’s disease process. The findings in the Journal of AlzheimerÂ’s Disease. Using mice bred to develop symptoms mimicking AlzheimerÂ’s disease, the USF team presents the first evidence that caffeinated coffee offers protection against the memory-robbing disease that is not possible with other caffeine-containing drinks...

Researchers at Mount Sinai School of Medicine have found that grape seed polyphenols—a natural antioxidant—may help prevent the development or delay the progression of Alzheimer's disease. The research, led by Giulio Maria Pasinetti, MD, PhD, The Saunder Family Professor in Neurology, and Professor of Psychiatry and Geriatrics and Adult Development at Mount Sinai School of Medicine, was published online in the current issue of the Journal of Alzheimer's Disease. This is the first study to evaluate the ability of grape-derived polyphenols to prevent the generation of a specific form of β-amyloid (Aβ) peptide, a substance in the brain long known...

New research on mice suggests vitamin D and transporter proteins found at the blood-brain barrier may help prevent amyloid beta peptide buildup in the brain — reducing the risk of Alzheimer’s disease. Experts say that advancing age is a major risk factor for Alzheimer’s disease (AD) with AD associated with build-up of the peptide amyloid beta in the brain. New research published in BioMed Central’s open access journal Fluids and Barriers of the CNS shows that removal of amyloid beta from the brain depends on vitamin D and also on an age-related alteration in the production of transporter proteins which...

The discovery has implications for the treatment of several diseases—as well as normal aging in healthy people. The drug rapamycin has been found to reverse the effects of Hutchinson-Gilford progeria syndrome, a fatal genetic disease that resembles rapid aging, in cells taken from patients with the disease. Rapamycin, an immunosuppressant drug used to prevent rejection of transplanted organs, has already been shown to extend life span in healthy mice. Researchers hope the findings will provide new insight into treating progeria as well as other age-related diseases. Skin cells from patients with progeria show a slew of defects: deformities in their...

Dementia sufferers are being killed by doctors in Holland under the country’s euthanasia laws, official figures are to reveal. A total of 21 patients with early-stage dementia, including Alzheimer’s, died by lethal injection last year, according to a forthcoming annual report. This is the first time dementia sufferers have been included in the country’s euthanasia statistics. None of the cases is thought to have involved any illegal act on the part of health professionals, and each time the patient was considered capable of giving their consent. But the figures have caused alarm among critics who say the pool of patients...

Glen Campbell has been diagnosed with Alzheimer’s disease, the 75-year-old country singer, songwriter and guitarist and his wife, Kim, have told People magazine, a condition that has prompted him to describe a new album coming in August as his final recording. "Glen is still an awesome guitar player and singer," Kim said in the interview. "But if he flubs a lyric or gets confused onstage, I wouldn’t want people to think, 'What's the matter with him? Is he drunk?' " Campbell is planning a series of concerts this fall in support of the album, “Ghost on the Canvas,” due Aug....

NASHVILLE – Country legend Glen Campbell has been diagnosed with Alzheimer's disease, his wife told People magazine Wednesday. Though the "Rhinestone Cowboy" singer has suffered from minor short-term memory loss for several years, the Alzheimer's diagnosis came about six months ago, wife Kim Campbell said. The 75-year-old has decided to give a set of farewell live performances this fall and his family wanted to go public with the news of his disease so the public would be aware of his condition. "Glen is still an awesome guitar player and singer," his wife told People. "But if he flubs a lyric...

Tampa, FL (June 21, 2011) – A yet unidentified component of coffee interacts with the beverage's caffeine, which could be a surprising reason why daily coffee intake protects against Alzheimer's disease. A new Alzheimer's mouse study by researchers at the University of South Florida found that this interaction boosts blood levels of a critical growth factor that seems to fight off the Alzheimer's disease process. The findings appear in the early online version of an article to be published June 28 in the Journal of Alzheimer's Disease. Using mice bred to develop symptoms mimicking Alzheimer's disease, the USF team presents...

A research breakthrough has proven that it is possible to reprogram mature cells from human skin directly into brain cells, without passing through the stem cell stage. The unexpectedly simple technique involves activating three genes in the skin cells; genes which are already known to be active in the formation of brain cells at the fetal stage. The new technique avoids many of the ethical dilemmas that stem cell research has faced. For the first time, a research group at Lund University in Sweden has succeeded in creating specific types of nerve cells from human skin. By reprogramming connective tissue...

As revelations about a possible scandal plaguing Rep. Anthony Weiner continue surface, the Democratic New York congressman continues to have defenders: On Monday’s broadcast of “The View,” co-host Barbara Walters went to bat for Weiner and proposed that the picture in question was intended for his wife and not for whom it was sent. “First of all, I have my own theory about why he took that picture, if indeed he did take that picture,” Walters said. “This is my theory – this doesn’t mean that it is right. He is married to this beautiful woman, whom I know, who...

Enlarge Image Green light. Antibodies that bind to the transferrin receptor (green) can cross the blood-brain barrier and potentially help deliver therapies to neurons (red). Credit: Yu et al., Science Translational Medicine Any would-be cure for Alzheimer’s disease or other brain disorder faces a daunting obstacle: the blood-brain barrier. This nearly impenetrable lining in the capillaries of the brain keeps out viruses and other bad guys, but it also denies entry to many potential drugs and other treatments. Now researchers have devised a way to trick one of the gatekeepers in this cellular defense system into escorting a potentially...

Stress hormones lead to Alzheimer-like protein modificationsProtein deposits in nerve cells are a typical feature of Alzheimer's disease: the excessive alteration of the tau protein through the addition of phosphate groups – a process known as hyperphosphorylation – causes the protein in the cells to aggregate into clumps. As a result, nerve cells die, particularly in the hippocampus, a part of the brain that plays an important role in learning and memory, as well as in the prefrontal cortex which regulates higher cognitive functions. Fewer than ten percent of Alzheimer cases have a genetic basis. The factors that contribute to...

Older people suffering from mild memory and cognition problems may be less likely to progress to full-blown Alzheimer’s disease if they receive treatment for medical conditions like diabetes, high blood pressure and cholesterol, a new study has found. In 2004, researchers at Daping Hospital in Chongqing, China, began following 837 residents ages 55 and older who had mild cognitive impairment but not dementia. Of these, 414 had at least one medical condition that can impair blood flow to the brain. After five years, 298 of the participants had developed Alzheimer’s. Subjects who had had high blood pressure or other vascular...